AstraZeneca to present pancreatic microislet data at EASD Annual Meeting

AstraZeneca to present pancreatic microislet data at EASD Annual Meeting 


The 51st annual European Association for the Study of Diabetes (EASD) meeting will take place in Stockholm, Sweden September 14-18.  It is the largest international scientific meeting on diabetes and its complications.  One of the more than 1200 abstracts being presented this year will feature work performed by AstraZeneca's Dr. Eva-Marie Andersson and colleagues using InSphero 3D InSight™ Pancreatic Microislets.  You can view the abstract entitled "Human pancreatic microislets as a standardised model for glucose stimulated insulin and glucagon secretion" on the EASD virtual meeting website.

Learn more about our long-lived, standardized 3D islet model system for diabetes and metabolism research by visiting the product page, or viewing our on demand webinar: 3D InSight™ Human Pancreatic Microislets and the Combined Power of HTRF® Technology.

Human Islets


Company video